 |
 |
 |
Pipeline |
|
|
Eurocor GmbH Product Pipeline Analysis
Publication Date August 2008
Publisher Global Markets Direct
Product Type Report
Pages 27
ISBN Number not applicable
Product Code GMD626
|
|
|
Summary
This report is an insightful source for data, analysis and strategic insights into a Eurocor GmbH's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.
Scope
- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.
Reasons to buy
- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.
|
Content
- 1.1 List Of Tables
- 1.2 List of Figures
- 2 Company Overview
- 2.1 Key Information
- 2.2 Industry Outlook - Cardiovascular Devices
- 3 Major Products and Services
- 3.1 Overview
- 4 Competitors
- 5 Locations And Subsidiaries
- 5.1 Head Office
- 5.2 Other Locations & Subsidiaries
- 6 Recent Developments
- 6.1 Product News
- 6.1.1 Dec 20, 2007: Opto Circuits Subsidiary Launches Dior; Will Tap Market Worth Us$1.20 Billion
- 6.1.2 Feb 20, 2007: Dior Recieves CE Certification
- 6.1.3 Jul 10, 2006: EuroCor Gets CE Approval For Taxcor-I DES
- 6.2 Product Approvals
- 6.2.1 Feb 20, 2007: Dior Recieves CE Certification
- 6.2.2 Jul 10, 2006: EuroCor Gets CE Approval For Taxcor-I DES
- 7 Eurocor GmbH Pipeline Products
- 7.1 Eurocor GmbH Product Pipeline Analysis
- 7.1.1 Eurocor GmbH Pipeline Products By Equipment Type
- 7.1.2 Eurocor GmbH Pipeline Products By Development Stage
- 7.1.3 Eurocor GmbH Pipeline Products By Therapy Area
- 7.1.4 Eurocor GmbH Pipeline Products By Clinical Trials
- 7.1.5 Eurocor GmbH Pipeline Products By News Summary
- 7.2 TAXCOR
- 7.2.1 Product Description
- 7.2.2 Product Status
- 7.2.3 Clinical Trials
- 7.2.4 Product Milestone
- 7.3 Genius MAGIC coronary stent system
- 7.3.1 Product Description
- 7.3.2 Product Status
- 7.4 Genius MEGAFLEX
- 7.4.1 Product Description
- 7.4.2 Product Status
- 7.4.3 Clinical Trials
- 7.5 Magic CC
- 7.5.1 Product Description
- 7.5.2 Product Status
- 7.5.3 Clinical Trials
- 7.6 RADIMAX Selfexpanding Nitinol Peripheral Stent System
- 7.6.1 Product Description
- 7.6.2 Product Status
- 7.7 JOKER Peripheral Balloon Catheter
- 7.7.1 Product Description
- 7.7.2 Product Status
- 7.8 FREEWAY Paclitaxel-Eluting Peripheral Balloon Catheter
- 7.8.1 Product Description
- 7.8.2 Product Status
- 7.9 Magico Stent
- 7.9.1 Product Description
- 7.9.2 Product Status
- 7.10 Drug coated renal stent
- 7.10.1 Product Description
- 7.10.2 Product Status
- 7.11 Genetic stent technology
- 7.11.1 Product Description
- 7.11.2 Product Status
- 7.12 RESORB
- 7.12.1 Product Description
- 7.12.2 Product Status
- 7.13 Minimally Invasive Neuroradiology Device
- 7.13.1 Product Description
- 7.13.2 Product Status
- 8 Appendix
- 8.1 Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Expert Panel Validation
- 8.2 Contact Us
- 8.3 About Global Markets Direct
- 8.4 Disclaimer
- 1 List of Tables
- Table 1: Eurocor GmbH,Key Facts
- Table 2: Eurocor GmbH, Subsidiaries
- Table 3: Eurocor GmbH Pipeline Products by Equipment Type
- Table 4: Eurocor GmbH Pipeline Products By Development Stage
- Table 5: Eurocor GmbH Pipeline Products By Therapy Area
- Table 6: Eurocor GmbH Pipeline Products By Clinical Trials
- Table 7: Eurocor GmbH Pipeline Products By News Summaries
- 1.2 List of Figures
- Figure 1: Eurocor GmbH Pipeline Products By Development Stage
- Figure 2: Global Markets Direct Methodology
|
|
| Scope |
Expert Insight/Opinion |
|
| Profiles |
In-depth Company Insight |
|
| Features |
Primary Research Data |
|
|